Managing the Oral Side-Effects of Medications Used to Treat Multiple Sclerosis

Australian Dental Journal- United States

doi 10.1111/adj.12510

Full Text

Abstract

Available in

Categories

Date

May 31, 2017

Authors

Publisher

Wiley

Related search

Siponimod: A New Approved Oral Drug to Treat Multiple Sclerosis

NeuroPharmac Journal

English

Multiple Sclerosis in 2015: Managing the Complexity of Multiple Sclerosis

Nature Reviews Neurology

Molecular Neuroscience

English

Targeting Dendritic Cells to Treat Multiple Sclerosis

Nature Reviews Neurology

Molecular Neuroscience

English

Angioplasty Used to Treat Multiple Sclerosis Patients: A Potential Revolution in Health Care Technology

Revue interdisciplinaire des sciences de la santé - Interdisciplinary Journal of Health Sciences

English

Molecular Pharmacodynamics of New Oral Drugs Used in the Treatment of Multiple Sclerosis

Drug Design, Development and Therapy

Pharmaceutical Science

English

Managing the Side Effects of Invasion Control

Multidisciplinary

Philosophy of Science

English

Managing Neuropsychological Impairment in Multiple Sclerosis

International Journal of MS Care

Specialized Nursing

English

Novel Medications to Treat Addictive Disorders

Current Psychiatry Reports

English

Managing Multiple Sclerosis: Treatment Initiation, Modification, and Sequencing

Canadian Journal of Neurological Sciences

English